Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
Submitted by
admin
on August 23, 2018 - 10:20am
Source:
CP WIre
News Tags:
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
Headline:
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
snippet:
Liver cancer is the second leading cause of cancer-related deaths
Treatment options for this type of liver cancer are limited
Lenvima is also approved in the US as first-line treatment
Do Not Allow Advertisers to Use My Personal information
